Intercure Ltd.
INCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857030
No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Intercure Ltd. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 19 | 18 | −1 |
| Shares | 4.91M | 6.58M | +1.67M (+34.0%) |
| Value | $34.8M | $38.1M | +$3.28M (+9.4%) |
New holders (4)
Institutions that held Intercure Ltd. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cohanzick Management, LLC | 128,525 | $748.0K | 0.21% |
| Tower Research Capital LLC (TRC) | 1,242 | $7.00K | 0.00% |
| Advisor Group Holdings, Inc. | 500 | $3.00K | 0.00% |
| Toronto Dominion Bank | 49 | $0 | 0.00% |
Sold out (5)
Institutions that held Intercure Ltd. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Jane Street Group, LLC | 14,520 | $103.0K |
| Citigroup Inc | 5,124 | $36.0K |
| Royal Bank of Canada | 1,955 | $14.0K |
| ARK Investment Management LLCSuperinvestorARK Invest | 257 | $2.00K |
| McCarthy Asset Management, Inc. | 150 | $1.00K |